Enliven Therapeutics, Inc. - ELVN
CEO
Director
PRESIDENT AND CEO
Direct Buys
0
$0
0
Shares
Direct Sells
0
$0
0
Shares
Indirect Buys
0
$0
0
Shares
Indirect Sells
15
($2.77) M
-114,633
Shares
Monthly Values
| Transaction | Filed | Type | Shares @ Price | Value | Balance ( Change % ) | Ownership |
|---|---|---|---|---|---|---|
|
05/19/2025
10b5-1
|
05/21/2025 |
Sell
|
-5,000 @ $16.49
|
($82,453) | 972,892 (-0.51%) | Indirect - See footnote |
|
05/02/2025
10b5-1
|
05/05/2025 |
Sell
|
-2,170 @ $20.00
|
($43,409) | 977,892 (-0.22%) | Indirect - See footnote |
|
05/01/2025
10b5-1
|
05/05/2025 |
Sell
|
-5,330 @ $20.08
|
($107,007) | 980,062 (-0.54%) | Indirect - See footnote |
|
04/17/2025
10b5-1
|
04/21/2025 |
Sell
|
-5,000 @ $16.42
|
($82,096) | 985,392 (-0.50%) | Indirect - See footnote |
|
03/17/2025
10b5-1
|
03/19/2025 |
Sell
|
-12,500 @ $20.83
|
($260,320) | 990,392 (-1.25%) | Indirect - See footnote |
|
10/18/2024
10b5-1
|
10/22/2024 |
Sell
|
-924 @ $30.00
|
($27,723) | 1,002,892 (-0.09%) | Indirect - See footnote |
|
10/09/2024
10b5-1
|
10/10/2024 |
Sell
|
-16,710 @ $28.15
|
($470,405) | 1,003,816 (-1.64%) | Indirect - See footnote |
|
10/08/2024
10b5-1
|
10/10/2024 |
Sell
|
-13,267 @ $27.96
|
($370,929) | 1,020,526 (-1.28%) | Indirect - See footnote |
|
10/07/2024
10b5-1
|
10/08/2024 |
Sell
|
-2,730 @ $27.50
|
($75,075) | 1,033,793 (-0.26%) | Indirect - See footnote |
|
10/04/2024
10b5-1
|
10/08/2024 |
Sell
|
-12,206 @ $27.51
|
($335,792) | 1,036,523 (-1.16%) | Indirect - See footnote |
|
10/01/2024
10b5-1
|
10/03/2024 |
Sell
|
-526 @ $27.54
|
($14,485) | 1,048,729 (-0.05%) | Indirect - See footnote |
|
08/26/2024
10b5-1
|
08/28/2024 |
Sell
|
-12,000 @ $22.89
|
($274,718) | 1,049,255 (-1.13%) | Indirect - See footnote |
|
07/31/2024
10b5-1
|
08/02/2024 |
Sell
|
-2,270 @ $27.56
|
($62,555) | 1,061,255 (-0.21%) | Indirect - See footnote |
|
07/25/2024
10b5-1
|
07/29/2024 |
Sell
|
-12,000 @ $24.92
|
($299,073) | 1,063,525 (-1.12%) | Indirect - See footnote |
|
06/25/2024
10b5-1
|
06/27/2024 |
Sell
|
-12,000 @ $21.66
|
($259,902) | 1,075,525 (-1.10%) | Indirect - See footnote |